Ready to take the next step?
If you’re looking for medical weight‑loss care that’s structured, supportive and led by licensed providers, MinuteClinic is here to help you understand your options.
FSA/HSA
Adults who used Wegovy® pen (semaglutide injection), along with diet and exercise, lost an average of 35 pounds.*
FSA/HSA
Adults who took Wegovy® pill (semaglutide tablet) achieved on average 14% weight loss* or approximately 33 pounds.
FSA/HSA
One out of three people taking Saxenda® (liraglutide) achieved significant weight loss of more than 10%,* or an average of 23 pounds.
FSA/HSA
Adults lost an average of 20.9% of their body weight* with Zepbound® (tirzepatide) 15 mg versus 3.1% with a placebo.
FSA/HSA
Taking Contrave® (naltrexone) along with diet and exercise, people can experience 2 to 4 times more weight loss than with diet and exercise alone.*
FSA/HSA
Xenical® (bupropion) is intended for adults with a BMI ≥30, or ≥27 with weight‑related conditions* such as high blood pressure, diabetes or high cholesterol.
Patients who took the highest dose of Foundayo™ (orforglipron molecule) as directed for 72 weeks lost an average of 27.3 pounds* or 12.4% of their body weight.
“My provider did a great job describing the medicine and directions to me during my visit. She is exceptional!”
— David, verified MinuteClinic review
“My provider is such a delight to see and her passion for the well-being of the patients in her office is evident in how she practices medicine.”
— Laura, verified MinuteClinic review
“It was easy to make an appointment that worked for my busy schedule.”
— Rick, verified MinuteClinic review
“My provider was very comprehensive in explaining my options for weight loss and addressing my concerns in a holistic fashion.”
— Stephanie, verified MinuteClinic review
A provider will review your treatment plan, discuss prescription refills if appropriate and help you continue your weight-loss care.
The MinuteClinic Weight-Loss Program is designed to give you the right tools and support to help you achieve your health and weight-loss goals.
MinuteClinic providers are trained to your health history, current medications and weight-loss goals to determine whether prescription weight-loss medication may be appropriate for you.*
During your weight-loss consultation, your MinuteClinic® provider will review your past medical history including current medical conditions, medications, height, weight, body mass index (BMI), diet, lifestyle and weight-loss goals. The provider will then determine if you are eligible for weight-loss medication and provide a personalized weight-loss plan for you.
GLP‑1 agonist medications can help your body control blood sugar when it’s high, help you feel full longer and contribute to weight loss.
You can receive a prescription for weight-loss medications through MinuteClinic® or any licensed health care provider if it is medically appropriate.
At MinuteClinic®, a provider can prescribe weight-loss medications virtually. Your provider will evaluate your overall health and will review your past medical history, current medications, height, weight and body mass index (BMI) to determine if you are a candidate for weight-loss medication.
If you qualify, they can prescribe FDA approved weight-loss medications in either pill or injectable form.
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK), weight‑loss medications are typically considered for adults with the following BMI:*
Weight-loss medications are prescription-only and should be used alongside lifestyle modifications, not as a standalone strategy.
If eligible, MinuteClinic providers will determine the best weight-loss medications for you. MinuteClinic providers can prescribe oral or injectable FDA approved weight-loss medications, including:
FDA approved medications ensure safety, efficacy and rigorous quality standards that give our providers and patients the confidence they need.
Yes. FDA approved GLP‑1 oral options include:
Yes. Research shows that oral GLP‑1 medications, like oral semaglutide, can produce metabolic results and weight loss similar to injectable GLP‑1s* when taken at effective doses and with good adherence. They work the same way in the body and offer a needle‑free alternative for many people.
Effectiveness depends on:
Injectables remain more widely studied for weight loss, but oral options are emerging as equally effective alternatives.
Yes, weight-loss pills are clinically proven to support meaningful weight reduction,* but they are most effective when combined with healthy eating, physical activity and medical supervision.
The actual cost you pay for semaglutide, or any other weight-loss medication, depends on your insurance coverage and if you are eligible for any discount programs.
If you are prescribed a weight-loss medication, board-certified providers will continue to evaluate you and may slowly adjust the dose about every four weeks to find the right dose that works best for you. Once your provider determines that the dose is right for you, it is recommended to schedule a visit once every three months.
Additional nutritional counseling, monitoring and injection training is also available in between your appointments.
In a follow-up visit, board-certified providers will continue to review your health status, lifestyle and weight loss to make sure you stay on track and your health needs are met.
If you’re looking for medical weight‑loss care that’s structured, supportive and led by licensed providers, MinuteClinic is here to help you understand your options.
*FOR RESTRICTIONS APPLY: $29 cash pay visit covers weight loss–related consultation only; price of labs not included.
*FOR TERMS APPLY: MinuteClinic® providers can prescribe GLP-1 agonists to patients who meet clinical eligibility criteria. GLP-1 supplies are not guaranteed to be available at a patient’s pharmacy of choice, and the medication may not be covered by insurance. GLP-1 prescribing may not be available in all states. Compounded GLP-1 and controlled-substance medications for weight loss are not prescribed at MinuteClinic (includes phentermine, among others).
*FOR SUBJECT TO RESTRICTIONS: For select GLP-1 meds from $149 with manufacturer coupon (no insurance) at participating pharmacies of your choice; eligibility and terms apply. Copays for as little as $25 eligibility varies based on insurance, manufacturer coupon, dose and brand; cash price may be higher. Availability subject to change. Restrictions apply.
*FOR LOST AN AVERAGE OF 35 POUNDS SOURCE: Novo Nordisk. Wegovy® pen results and weight loss data. Accessed August 3, 2026.
*FOR ACHIEVED ON AVERAGE 14% WEIGHT LOSS SOURCE: American College of Cardiology. OASIS 4: significant weight loss with oral semaglutide comparable with high-dose, SC versions. Published September 24, 2025. Accessed August 3, 2026.
*FOR ACHIEVED SIGNIFICANT WEIGHT LOSS OF MORE THAN 10% SOURCE: Novo Nordisk. Saxenda® clinical trials for weight loss results. Accessed August 3, 2026.
*FOR LOST AN AVERAGE OF 20.9% OF THEIR BODY WEIGHT SOURCE: Eli Lilly and Company. Clinical data, safety & study design | Zepbound®. Accessed August 3, 2026.
*FOR PEOPLE CAN EXPERIENCE 2 TO 4 TIMES MORE WEIGHT LOSS THAN WITH DIET AND EXERCISE ALONE SOURCE: Currax Pharmaceuticals LLC. Results with Contrave®. Accessed August 3, 2026.
*FOR INTENDED FOR ADULTS WITH A BMI ≥30—OR ≥27 WITH WEIGHT-RELATED CONDITIONS SOURCE: MedLibrary.org. XENICAL® prescribing information. Revised July 2024. Accessed August 3, 2026.
*FOR LOST AN AVERAGE OF 27.3 POUNDS SOURCE: Eli Lilly and Company. FDA Approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions. Published April 1, 2026. Accessed August 3, 2026.
*FOR DETERMINE WHETHER PRESCRIPTION WEIGHT-LOSS MEDICATION MAY BE APPROPRIATE FOR YOU: MinuteClinic® providers can prescribe GLP-1 agonists to patients who meet clinical eligibility criteria. GLP-1 supplies are not guaranteed to be available at a patient’s pharmacy of choice, and the medication may not be covered by insurance. GLP-1 prescribing may not be available in all states. Compounded GLP-1 and controlled substance medications for weight loss are not prescribed at MinuteClinic (includes phentermine, among others).
*FOR WEIGHT-LOSS MEDICATIONS ARE TYPICALLY CONSIDERED FOR ADULTS WITH THE FOLLOWING BMI SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK). Prescription medications to treat overweight & obesity. Reviewed June 2024. Accessed August 3, 2026.
*FOR An oral semaglutide approved for type 2 diabetes that can also help control appetite and may lead to weight loss source: American Diabetes Association. Starting FDA‑approved weight management medications. Published June 26, 2025. Accessed February 4, 2026.
*FOR A HIGHER-DOSE ORAL SEMAGLUTIDE THAT THE FDA APPROVED IN DECEMBER 2025 SPECIFICALLY FOR WEIGHT LOSS SOURCE: New England Journal of Medicine. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity. Published September 17, 2025. Accessed February 4, 2026.
*FOR Foundayo™ (orforglipron), an FDA approved GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions SOURCE: Eli Lilly and Company. FDA approves Lilly's Foundayo™ (orforglipron), the Only GLP-1 Pill for Weight Loss That Can Be Taken Any Time of day without Food or Water Restrictions. Published April 1, 2026. Accessed August 3, 2026.
*FOR ORAL GLP-1 MEDICATIONS, LIKE ORAL SEMAGLUTIDE, CAN PRODUCE METABOLIC RESULTS AND WEIGHT LOSS SIMILAR TO INJECTABLE GLP-1s SOURCE: National Institutes of Health (NIH), PubMed Central. Comparative analysis of oral vs. injectable semaglutide effectiveness and safety (PMCID: PMC11559783). Published November 5, 2024. Accessed February 4, 2026.
*FOR WEIGHT-LOSS PILLS ARE CLINICALLY PROVEN TO SUPPORT MEANINGFUL WEIGHT REDUCTION SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK). Prescription medications to treat overweight & obesity. Reviewed June 2024. Accessed February 4, 2026.